Figure 3. PRPM improves nonalcoholic fatty liver disease. (A) H&E staining, ×100, ×200, ×400; Oil red staining, ×200, ×400. (B) Quantitative analysis of the Oil red O staining-positive area (%). (C–G) ELISA analysis of the insulin index, serum triglycerides (TG), alanine aminotransferase (ALT), tumor necrosis factor-α (TNF-α), and interleukin-6 (IL-6). *indicates a comparison with NC, P < 0.05. #indicates a comparison with NAFLD, P < 0.05. The white line indicates 50 μm.